N A Marsh
Overview
Explore the profile of N A Marsh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
203
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Raymond P, Ray M, Callen S, Marsh N
Perfusion
. 2003 Nov;
18(5):277-81.
PMID: 14604243
Activated clotting time (ACT) values were converted to heparin concentration, enabling an assessment of the accuracy of the ACT and a quantification of the prolongation imposed by bypass. Blood samples...
2.
Raymond P, Ray M, Callen S, Marsh N
Perfusion
. 2003 Nov;
18(5):269-76.
PMID: 14604242
There is limited published data on the agreement between techniques for monitoring heparin levels. The aim of this study was to validate the Hepcon/HMS, with particular focus on the agreement...
3.
Marsh N
Haemostasis
. 2002 Mar;
31(3-6):211-7.
PMID: 11910187
Snake venom toxins are invaluable for the assay of coagulation factors and for the study of haemostasis generally. Thrombin-like enzymes (SVTLE) are used for fibrinogen and fibrinogen breakdown product assays...
4.
Raymond P, Marsh N
Blood Coagul Fibrinolysis
. 2001 Dec;
12(8):601-18.
PMID: 11734660
Cardiopulmonary bypass (CPB) is routinely utilized to provide circulatory support during cardiac surgical procedures. The morbidity of CPB has been significantly reduced since its introduction 50 years ago; however, cerebral...
5.
Pecheniuk N, Morris C, Walsh T, Marsh N
Blood Coagul Fibrinolysis
. 2001 Jun;
12(3):201-6.
PMID: 11414634
Recently, a polymorphism was identified in exon 25 of the factor V gene that is possibly a functional candidate for the HR2 haplotype. This haplotype is characterized by a single...
6.
Pavey S, Hawson G, Marsh N
Blood Coagul Fibrinolysis
. 2001 Mar;
12(1):51-8.
PMID: 11229827
Comprehensive studies of fibrinolysis in non-small cell lung carcinoma have been limited, and assignment of patients to high/low prognosis groups based on arbitrary cut-offs utilizing fibrinolytic measurements is unstandardized. This...
7.
Pecheniuk N, Walsh T, Marsh N
Blood Coagul Fibrinolysis
. 2001 Jan;
11(8):683-700.
PMID: 11132646
With the identification of common single locus point mutations as risk factors for thrombophilia, many DNA testing methodologies have been described for detecting these variations. Traditionally, functional or immunological testing...
8.
Pecheniuk N, Marsh N, Walsh T
Blood Coagul Fibrinolysis
. 2000 Apr;
11(2):183-9.
PMID: 10759012
We have previously reported the use of a novel mini-sequencing protocol for detection of the factor V Leiden variant, the first nucleotide change (FNC) technology. This technology is based on...
9.
Gattullo D, Pagliaro P, Marsh N, Losano G
Life Sci
. 1999 Nov;
65(21):2167-74.
PMID: 10576588
Since its discovery over 20 years ago as an intercellular messenger, nitric oxide (NO), has been extensively studied with regard to its involvement in the control of the circulation and,...
10.
Pavey S, Hawson G, Marsh N
Blood Coagul Fibrinolysis
. 1999 Aug;
10(5):261-7.
PMID: 10456617
Although fibrinolysis has been implicated in the progression and metastasis of lung cancer, no detailed study has been carried out on components measured in samples from both plasma and tumour....